Your browser doesn't support javascript.
loading
Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease.
Iluta, Sabina; Pasca, Sergiu; Dima, Delia; Mester, Gabriela; Urian, Laura; Bojan, Anca; Zdrenghea, Mihnea; Trifa, Adrian; Balacescu, Ovidiu; Tomuleasa, Ciprian.
Affiliation
  • Iluta S; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  • Pasca S; Medfuture Research Center for Advanced Medicine, Iuliu HaTieganu University of Medicine and Pharmacy Faculty of Medicine, Cluj Napoca, Romania.
  • Dima D; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania.
  • Mester G; Department of Hematology, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania.
  • Urian L; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  • Bojan A; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  • Zdrenghea M; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  • Trifa A; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania.
  • Balacescu O; Department of Genetics, Ion Chiricuta Oncology Institute, Cluj Napoca, Romania.
  • Tomuleasa C; Department of Hematology, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj Napoca, Romania ciprian.tomuleasa@umfcluj.ro.
Eur J Hosp Pharm ; 29(6): e8, 2022 11.
Article in En | MEDLINE | ID: mdl-33541912
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Hematology Limits: Humans Language: En Journal: Eur J Hosp Pharm Year: 2022 Document type: Article Affiliation country: Rumanía Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: COVID-19 / Hematology Limits: Humans Language: En Journal: Eur J Hosp Pharm Year: 2022 Document type: Article Affiliation country: Rumanía Country of publication: Reino Unido